KR20050115276A - 신규한 조성물 - Google Patents

신규한 조성물 Download PDF

Info

Publication number
KR20050115276A
KR20050115276A KR1020057016853A KR20057016853A KR20050115276A KR 20050115276 A KR20050115276 A KR 20050115276A KR 1020057016853 A KR1020057016853 A KR 1020057016853A KR 20057016853 A KR20057016853 A KR 20057016853A KR 20050115276 A KR20050115276 A KR 20050115276A
Authority
KR
South Korea
Prior art keywords
formulation
fentanyl
spray
container
polar organic
Prior art date
Application number
KR1020057016853A
Other languages
English (en)
Korean (ko)
Inventor
캘빈 로스
클리브 부울스
알리스타르 캠프벨
Original Assignee
아라키스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by 아라키스 리미티드 filed Critical 아라키스 리미티드
Publication of KR20050115276A publication Critical patent/KR20050115276A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020057016853A 2003-03-11 2004-03-11 신규한 조성물 KR20050115276A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0305579.5 2003-03-11
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023.7 2003-12-03
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation

Publications (1)

Publication Number Publication Date
KR20050115276A true KR20050115276A (ko) 2005-12-07

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057016853A KR20050115276A (ko) 2003-03-11 2004-03-11 신규한 조성물

Country Status (10)

Country Link
EP (1) EP1608372A2 (ja)
JP (1) JP2006519770A (ja)
KR (1) KR20050115276A (ja)
AU (1) AU2004218876B2 (ja)
BR (1) BRPI0408209A (ja)
CA (1) CA2516338A1 (ja)
MX (1) MXPA05009602A (ja)
NO (1) NO20054172L (ja)
NZ (1) NZ541781A (ja)
WO (1) WO2004080382A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089082A2 (en) 2005-02-17 2006-08-24 Velcera Pharmaceuticals Transmucosal administration of drug compositions for treating and preventing disorders in animals
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
BRPI0707235B8 (pt) * 2006-01-25 2021-05-25 Insys Therapeutics Inc formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
NO2180844T3 (ja) 2007-08-02 2018-07-21
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010389A1 (de) * 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische zusammensetzung
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP1029536B1 (en) * 1997-10-01 2007-11-28 Novadel Pharma Inc. Buccal non-polar spray
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
AU2001262992A1 (en) * 2000-05-10 2002-02-18 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung

Also Published As

Publication number Publication date
MXPA05009602A (es) 2005-11-08
WO2004080382A3 (en) 2005-03-24
BRPI0408209A (pt) 2006-02-14
NO20054172L (no) 2005-10-06
WO2004080382A2 (en) 2004-09-23
CA2516338A1 (en) 2004-09-23
EP1608372A2 (en) 2005-12-28
AU2004218876A1 (en) 2004-09-23
AU2004218876B2 (en) 2007-08-02
NZ541781A (en) 2008-04-30
JP2006519770A (ja) 2006-08-31
NO20054172D0 (no) 2005-09-07

Similar Documents

Publication Publication Date Title
US20060062812A1 (en) Novel compositions
EP1446119B1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
US20090270438A1 (en) Novel compositions and formulations
KR20070104884A (ko) 아젤라스틴을 포함하는 조성물 및 이의 사용 방법
EP2436375B1 (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
CZ281931B6 (cs) Sulfát 3-/2-(dimethylamino)ethyl-N-methyl-1H-indol-5-methansulfonamidu a farmaceutické prostředky s jeho obsahem
CA2666581A1 (en) Buprenorphine-containing non-pressurised spray composition for transmucosal administration
EP1904032B1 (en) Fentanyl formulation containing an essential oil
CA2673049C (en) Stable anti-nausea oral spray formulations and methods
US8802058B2 (en) Pharmaceutical compositions and methods for administering the same
WO2009127878A1 (en) A liquid spray solution comprising buprenorphine, ethanol and an antioxidant
AU2004218876B2 (en) Novel compositions containing fentanyl
GB2399286A (en) Sub-lingual fentanyl formulation
US20220370445A1 (en) Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
US20090180969A1 (en) Pharmaceutical formulation comprising an anticholinergic drug
KR102375232B1 (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
TR201612324A1 (tr) Solunum Yolu Hastalıklarında Kullanılan Farmasötik Terkipler
WO2022166724A1 (zh) 一种福多司坦吸入用溶液制剂及其制备方法和用途
AU2002329578B2 (en) Compositions for treatment of common cold
CA3150070A1 (en) APOMORPHINE FORMULATION
AU2002329578A1 (en) Compositions for treatment of common cold

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application